Mirvie, a prenatal diagnostics company has received a $4.6M grant from the Bill & Melinda Gates Foundation to support the company’s efforts to predict unexpected pregnancy complications before they happen by revealing the underlying biology of each pregnancy for women on a global scale. Specifically, the funding will help launch study sites in Cameroon, Ghana, and Zambia to understand preeclampsia among pregnant…
Autoimmune disease happens when the body’s natural defense system can’t tell the difference between own cells and foreign cells, causing the body to attack normal cells mistakenly. One of the most common autoimmune diseases is multiple sclerosis (in short MS), a potentially disabling disease of the central nervous system. In MS, the immune system attacks the protective sheath that covers nerve fibers and causes communication…
JAMA Oncology has just published data from the Zai Lab‘s Phase 3 PRIME study, highlighting the positive outcomes of ZEJULA (niraparib) as a first-line maintenance therapy for Chinese patients with advanced ovarian cancer. The study reveals that ZEJULA significantly prolongs progression-free survival and reduces the risk of disease progression or death by 55%. These findings offer hope for improved outcomes in a…
French biotech company Ziwig has achieved a significant breakthrough in the field of endometriosis diagnosis with the validation of their Ziwig Endotest as a highly effective diagnostic tool. The study, published in the renowned New England Journal of Medicine (NEJM) Evidence, confirms the performance and reproducibility of Ziwig Endotest, boasting sensitivity and specificity rates exceeding 95%. This non-invasive test offers an alternative…
Freya Biosciences, a biotech company specializing in women’s health, has released positive topline results from the Phase 1 clinical trial of FB101, their vaginal microbial immunotherapeutic. The trial focused on addressing asymptomatic vaginal dysbiosis, a common condition in women undergoing infertility treatments. The findings show promise for improving fertility outcomes, particularly in in vitro fertilization (IVF) procedures. Freya Biosciences, headquartered in Copenhagen,…
Thermo Fisher Scientific has announced that its novel immunoassays, the Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR biomarkers, have received clearance from the U.S. Food and Drug Administration (FDA). These breakthrough biomarkers are the first and only immunoassays to be cleared for the risk assessment and clinical management of preeclampsia, a severe complication during pregnancy. Preeclampsia is a dangerous…
Vertex Ventures HC, a global healthcare investment firm led by women, has announced the launch of its third and largest fund of $200M, Fund III. The primary objective of Fund III is to back life sciences and medical technology companies focused on driving advancements in healthcare anad enhancing patient outcomes. “As technology continues to reshape industries and science continues to advance, VVHC…
Vistagen, a biopharma company focused on developing treatments for anxiety, depression, and other central nervous system disorders, has announced positive results from an exploratory Phase 2A study of PH80 in women diagnosed with menopausal hot flashes. The study, which involved 36 participants, demonstrated statistically significant efficacy of PH80 nasal spray compared to a placebo. The Phase 2A clinical study was designed to…
